These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15592334

  • 1. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand.
    Wang B, Nichol JL, Sullivan JT.
    Clin Pharmacol Ther; 2004 Dec; 76(6):628-38. PubMed ID: 15592334
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study.
    Kumagai Y, Fujita T, Ozaki M, Sahashi K, Ohkura M, Ohtsu T, Arai Y, Sonehara Y, Nichol JL.
    J Clin Pharmacol; 2007 Dec; 47(12):1489-97. PubMed ID: 17925591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
    Newland A, Caulier MT, Kappers-Klunne M, Schipperus MR, Lefrere F, Zwaginga JJ, Christal J, Chen CF, Nichol JL.
    Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981
    [Abstract] [Full Text] [Related]

  • 5. Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study.
    Sheng XY, Liu ZY, Zhao J, Song L, Zhao WM, Zhao X, Cui YM.
    Platelets; 2022 Nov 17; 33(8):1185-1191. PubMed ID: 35549802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.
    Case BC, Hauck ML, Yeager RL, Simkins AH, de Serres M, Schmith VD, Dillberger JE, Page RL.
    Stem Cells; 2000 Nov 17; 18(5):360-5. PubMed ID: 11007920
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul 17; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 11. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women.
    Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM.
    J Bone Miner Res; 2004 Jul 17; 19(7):1059-66. PubMed ID: 15176987
    [Abstract] [Full Text] [Related]

  • 12. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers.
    Trinchard-Lugan I, Ho-Nguyen Q, Bilham WM, Buraglio M, Ythier A, Munafo A.
    Eur Cytokine Netw; 2001 Jul 17; 12(3):391-8. PubMed ID: 11566619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thrombopoietin therapy increases platelet yields in healthy platelet donors.
    Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J.
    Blood; 2001 Sep 01; 98(5):1339-45. PubMed ID: 11520780
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.
    Gow JM, Tsuji WH, Williams GJ, Mytych D, Sciberras D, Searle SL, Mant T, Gibbs JP.
    Arthritis Res Ther; 2015 Oct 08; 17():282. PubMed ID: 26449617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
    Asai F, Jakubowski JA, Naganuma H, Brandt JT, Matsushima N, Hirota T, Freestone S, Winters KJ.
    Platelets; 2006 Jun 08; 17(4):209-17. PubMed ID: 16769598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.